Post by
venturetown on Nov 06, 2024 8:13am
BioVaxys to Participate in the US Government (BARDA)
Biovaxys will collaborate with top companies like AstraZeneca, Novavax, Ginko Bioworks, and others. This puts Biovaxys at the heart of vaccine innovation. The RRPV aims to accelerate the development vaccines and therapeutics, including Biovaxys's DPX vaccine technology. This could be key in BARDA's priority vaccine programs.